Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. - Wikidata - awgldk - TriplyDB

Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer.

Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer.

http://www.wikidata.org/entity/Q46320846

about

Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.Stereotactic radiosurgery and stereotactic body radiation therapy cost-effectiveness results.Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer?Cost effectiveness of telecare management for pain and depression in patients with cancer: results from a randomized trial.Cost-effectiveness of preoperative biliary drainage for obstructive jaundice in pancreatic and periampullary cancer.Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer Meta-analyses of treatment standards for pancreatic cancer.Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.Making the case for cost-effectiveness research.Stereotactic body radiation therapy in pancreatic cancer: the new frontier.Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions.Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review.The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma.Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement.Comparative Effectiveness of Resection vs Surveillance for Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasms With Worrisome Features.Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival.Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.Treatment of borderline resectable pancreatic cancer.Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis.

P2860

Q28267134-E26915E0-9E8A-4DA5-9EBB-46205D8C2759 Q30455481-105E8D8D-3B7C-4300-B8BA-1EB23503B71D Q33419384-A81B91DB-E53F-465E-AC0D-B77DFD739E29 Q34615959-7EC71594-6099-44CD-A1B8-57C11735C6C0 Q34759802-1CD1E537-36BE-4120-B294-F28BA7A5A729 Q35382059-CEACBEFF-AC86-469A-8A3A-42D2B5D87DC6 Q36640493-51912DDC-CA98-4A63-8BC6-14FBDFF31AFA Q36715792-30A3FCF5-E469-407E-8B49-C862959E176A Q37285956-94465A49-418A-41C3-896E-AB7503D05CEF Q38174478-69E013C6-AB4D-4FB6-BABC-2BF52DF63BB3 Q38245676-D89D3A65-147C-4D29-B13D-ADB53DC293CF Q38783194-9A1B3191-BB01-453C-A07B-269B409DDD70 Q39249966-67CEFB3C-6244-4525-A65F-DDF3C8098B04 Q44445114-2E4FB4EF-E8E7-481F-B770-77F0975D49DC Q44617854-1B2D0515-D5F8-4BA2-B3D0-4E4CD490D1A9 Q45073752-F7FA2DA5-D4C4-4C9C-B3FB-1CADC5A8073C Q47146583-626FA68A-35BD-4331-9287-B5044C75AFB6 Q50074188-7F1BCC29-0A6C-4C68-9BA6-A1ECD2A46689 Q51196995-E772128F-7AE8-43B4-8F67-86F343769A97 Q51831319-83969B6F-DEA3-43A5-8505-A140F76301EA

P2860

Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer.

http://www.wikidata.org/entity/Q46320846

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Cost-effectiveness of modern r ...... ly advanced pancreatic cancer.

@en

Cost-effectiveness of modern r ...... ly advanced pancreatic cancer.

@nl

type

label

Cost-effectiveness of modern r ...... ly advanced pancreatic cancer.

@en

Cost-effectiveness of modern r ...... ly advanced pancreatic cancer.

@nl

prefLabel

Cost-effectiveness of modern r ...... ly advanced pancreatic cancer.

@en

Cost-effectiveness of modern r ...... ly advanced pancreatic cancer.

@nl

P1433

Q46320846-4A443FD6-CDBA-47C2-9F56-675E4510D5AD

P1476

Q46320846-56A84508-6899-4CA4-B218-0138729F34EA

P2093

Q46320846-07514E27-0180-4EB3-8A4C-2632D370EC48

Q46320846-8123AA99-8165-47BC-BEDF-96F164E178DE

Q46320846-8DE732EB-8312-481D-978F-000A3E41AC98

Q46320846-8E7B3AC7-7212-4FE0-8F7C-B7B37244080A

Q46320846-D6795927-396C-4735-BA61-AA8BD58883CF

Q46320846-D96CADE7-CDF5-4016-BDA7-1988B0C1E68B

P2860

Q46320846-04C069DA-458E-4072-A6B7-C8235537D969

Q46320846-321A13DA-EACC-44B8-BC94-51FEABFA1F2B

Q46320846-4B86E892-18EE-4EB7-9B90-540901CD473E

Q46320846-5EB55D5A-C4AC-45F3-B166-66E96F091C66

Q46320846-5EC547AB-FD60-464C-8641-96BD413C8383

Q46320846-62D563ED-B98C-4AB3-ABB8-2D69DE2EB200

Q46320846-8814F4BD-BE35-49B9-8566-358752E5E86A

Q46320846-9858CE9F-C7D0-471D-915D-7DD2DE92481D

Q46320846-9885698D-00BD-433B-90D6-8834149B85CA

Q46320846-A8666D5C-EC36-444A-B66B-5EB5721AC1C7

P304

Q46320846-1BB1712E-491B-4E09-A788-41E923B63DAB

P31

Q46320846-DF1CBD1E-15BD-4CBB-958A-0275BE360771

P356

Q46320846-E525BF12-8136-4AD8-AF3A-211ADA018815

P407

Q46320846-543370F3-750E-4CFF-947A-C1E5D9F280AA

P433

Q46320846-53ECD4F1-4A38-47C3-B81D-E564F56D3AB5

P478

Q46320846-04D9DB70-6292-460A-9AFB-D2000AA83CA5

P50

Q46320846-446DEEC4-D699-4BDC-882B-914302E13E99

P577

Q46320846-F1BD3D09-4834-4474-831B-12EC0114808A

P5875

Q46320846-C56285A8-D885-4C15-936B-97E8BB280650

P698

Q46320846-110936DB-7ADC-4001-A95A-F3AB58FBC7EE

P921

Q46320846-0CFA66F7-D4ED-4198-AA51-55B361361D5A

P356

P1433

P1476

Cost-effectiveness of modern r ...... ly advanced pancreatic cancer.

@en

P2093

Daniel T Chang

http://www.w3.org/2001/XMLSchema#string

Heidi N Yeung

http://www.w3.org/2001/XMLSchema#string

James D Murphy

http://www.w3.org/2001/XMLSchema#string

Jon Abelson

http://www.w3.org/2001/XMLSchema#string

Lorene M Nelson

http://www.w3.org/2001/XMLSchema#string

Megan E Daly

http://www.w3.org/2001/XMLSchema#string

P2860

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

What is the price of life and why doesn't it increase at the rate of inflation?

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.

A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

Pancreatic cancer: total costs and utilization of health services.

Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.

Managed care, hospice use, site of death, and medical expenditures in the last year of life.

P304

1119-1129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.26365

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Albert C. Koong

P577

2011-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51506618

http://www.w3.org/2001/XMLSchema#string

P698

21773972

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy